Evidence map›Paper›PMID 33902572›Full record

ArticleRespiratory research2021

Practical application and validation of the 2018 ATS/ERS/JRS/ALAT and Fleischner Society guidelines for the diagnosis of idiopathic pulmonary fibrosis.

Angela R Shih, Chayanin Nitiwarangkul, Brent P Little, Benjamin W Roop, Sreyankar Nandy, Margit V Szabari, Nathaniel Mercaldo, Sarah Mercaldo, Sydney B Montesi, Ashok Muniappan and 4 more

Abstract readValidation Study
In one paragraph

Article in Respiratory research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. American journal of respiratory and critical care medicine · 2024
    Article
  9. Article
  10. Article
  11. Usual interstitial pneumonia (UIP): a clinically significant pathologic diagnosis.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2022
    Review
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Angela R Shih *Department of Pathology, Massachusetts General Hospital, 55 Fruit St, Boston, MA, 02114, USA.
Chayanin Nitiwarangkul *Department of Radiology, Massachusetts General Hospital, Boston, MA, USA.
Brent P LittleDepartment of Radiology, Massachusetts General Hospital, Boston, MA, USA.
Benjamin W RoopDivision of Pulmonary and Critical Care Medicine, Massachusetts General Hospital, Boston, MA, USA.
Sreyankar NandyDivision of Pulmonary and Critical Care Medicine, Massachusetts General Hospital, Boston, MA, USA.
Margit V SzabariDivision of Pulmonary and Critical Care Medicine, Massachusetts General Hospital, Boston, MA, USA.
Nathaniel MercaldoDepartment of Radiology, Massachusetts General Hospital, Boston, MA, USA.
Sarah MercaldoDepartment of Radiology, Massachusetts General Hospital, Boston, MA, USA.
Sydney B MontesiDivision of Pulmonary and Critical Care Medicine, Massachusetts General Hospital, Boston, MA, USA.
Ashok MuniappanDivision of Thoracic Surgery, Massachusetts General Hospital, Boston, MA, USA.
Sarita R BerigeiDivision of Pulmonary and Critical Care Medicine, Massachusetts General Hospital, Boston, MA, USA.
David A LynchDepartment of Radiology, National Jewish Health, Denver, CO, USA.
Amita Sharma *Department of Radiology, Massachusetts General Hospital, Boston, MA, USA.
Lida P Hariri *Department of Pathology, Massachusetts General Hospital, 55 Fruit St, Boston, MA, 02114, USA. LHARIRI@mgh.harvard.edu.

Funding

In vivo endobronchial OCT for IPF diagnosis and therapy response assessmentR01HL152075 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI HARIRI, LIDA P · 2020 to 2024
$4.0M
Low risk in vivo diagnosis of IPF with optical imagingK23HL132120 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI HARIRI, LIDA P · 2016 to 2020
$896k
Vascular Leak and Outcomes in IPFK23HL150331 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI MONTESI, SYDNEY · 2020 to 2024
$887k
NHLBI NIH HHS K23 HL132120NHLBI NIH HHS K23 HL150331NHLBI NIH HHS R01 HL152075NIH HHS K23HL132120NIH HHS R01HL152075
6 · The paper itself

Abstract

backgroundAccurate diagnosis of idiopathic pulmonary fibrosis (IPF) is essential to inform prognosis and treatment. In 2018, the ATS/ERS/JRS/ALAT and Fleischner Society released new diagnostic guidelines for usual interstitial pneumonitis (UIP)/IPF, adding Probable UIP as a CT category based on prior studies demonstrating this category had relatively high positive predictive value (PPV) for histopathologic UIP/Probable UIP. This study applies the 2018 ATS/ERS/JRS/ALAT and Fleischner Society guidelines to determine test characteristics of CT categories in academic clinical practice.

methodsCT and histopathology were evaluated by three thoracic radiologists and two thoracic pathologists. Comparison of consensus categorization by the 2018 ATS and Fleischner Society guidelines by CT and histopathology was performed.

resultsOf patients with CT UIP, 87% (PPV, 95% CI: 60-98%) had histopathologic UIP with 97% (CI: 90-100%) specificity. Of patients with CT Probable UIP, 38% (PPV, CI: 14-68%) had histopathologic UIP and 46% (PPV, CI: 19-75%) had either histopathologic UIP or Probable UIP, with 88% (CI: 77-95%) specificity. Patients with CT Indeterminate and Alternative Diagnosis had histopathologic UIP in 27% (PPV, CI: 6-61%) and 21% (PPV, CI: 11-33%) of cases with specificities of 90% (CI: 80-96%) and 25% (CI: 16-37%). Interobserver variability (kappa) between radiologists ranged 0.32-0.81.

conclusionsCT UIP and Probable UIP have high specificity for histopathologic UIP, and CT UIP has high PPV for histopathologic UIP. PPV of CT Probable UIP was 46% for combined histopathologic UIP/Probable UIP. Our results indicate that additional studies are needed to further assess and refine the guideline criteria to improve classification performance.

Indexed as

AdultAgedAged, 80 and overBiopsyFemaleHumansIdiopathic Pulmonary FibrosisLungMaleMiddle AgedObserver VariationPractice Guidelines as TopicPredictive Value of TestsReproducibility of ResultsSocieties, MedicalTomography, X-Ray ComputedInterstitial lung diseaseLung fibrosisPulmonary fibrosisRadiology and other imaging

Identifiers

PMID33902572
PMCPMC8074481

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.